Brachytherapy News and Research

RSS

Brachytherapy is a minimally invasive procedure that involves the use of radioactive seeds the size of rice grains. Brachytherapy, an out-patient procedure, usually takes 45 minutes to an hour to perform. Most patients can return to their normal activities within days. The success rates of prostate brachytherapy have compared favorably with success rates of radical prostatectomy and external beam radiation. In comparison studies, prostate brachytherapy has shown to have a favorable side effect profile when compared with other modalities. Clinical studies have shown that prostate brachytherapy has a cure rate of 94% for appropriately selected patients.

Prostate brachytherapy causes fewer side effects than surgery

Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.

28 Feb 2007

Seed implants critical for achieving a better prostate cancer outcome

More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology - Biology - Physics, the official journal of ASTRO.

31 Jan 2007

Radiation therapy combo cures prostate cancer long-term

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.

7 Jan 2007

BlueCross BlueShield of Illinois adds coverage for MammoSite

BlueCross BlueShield of Illinois after meeting with experts last week has decided to cover the partial-breast radiation therapy known as MammoSite for patients with early stage breast cancer, officials for the insurer said, the Chicago Sun-Times reports.

20 Sep 2006

Blue Cross Blue Shield of Illinois coverage policy for partial-breast radiation therapy to be reviewed

Blue Cross Blue Shield of Illinois' policy that it does not cover partial-breast radiation therapy was scheduled to be reviewed last Wednesday in Dallas during a three-day meeting of Health Care Service Corporation officials, the Chicago Sun-Times reports.

18 Sep 2006

Variances in patterns of care for patients with prostate cancer failing primary therapy

Variables that impact management of failed primary therapy for prostate cancer (CaP) are not well defined.

21 Aug 2006

Review identifies factors that influence patient treatment choice for localized prostate cancer

Variables that influence a patients' choice of treatment for localized prostate cancer (CaP) are identified in a literature review that is authored by Dr. Zeliadt and colleagues and appears in the on-line version of Cancer, 2006.

14 Jun 2006

Breast radiation device associated with complications

Doctors in New England have discovered that patients receiving accelerated-partial breast radiation therapy using a balloon brachytherapy system after lumpectomy for breast cancer can develop seroma, the retaining of fluid, in their breast which can require aspiration or make monitoring them by physical exam more difficult.

1 Jun 2006

Review identifies factors that influence patient treatment choice for localized prostate cancer

16 May 2006

Review examines the management of radiotherapy induced rectourethal fistula

Rectourethral fistulas (RUF) are a challenging problem observed by urological and colorectal surgeons.

11 Apr 2006

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.

11 Apr 2006

Sirolimus-releasing stents more effective than vascular brachytherapy for treating restenosis within a stent

David R. Holmes, Jr., M.D., of Mayo Clinic, Rochester, Minn., and colleagues with the SISR trial compared the use of vascular brachytherapy (VBT - intra-coronary radiation therapy) with implantation of the sirolimus-eluting stent for the treatment of restenosis occurring within a previously placed bare-metal stent

13 Mar 2006

Stents that release the drug paclitaxel to treat stenosis more effective than radiation therapy

Insertion of stents that release the drug paclitaxel to treat stenosis within an implanted bare-metal stent in a coronary artery reduces the risk of subsequent re-narrowing within the stent, when compared with treatment using intra-coronary radiation

13 Mar 2006

Drug-eluting stents best treatment for managing coronary restenosis

In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.

13 Mar 2006

New radiation therapy for prostate cancer has fewer side effects

A new radiation therapy for prostate cancer -- Cesium-131 brachytherapy -- has fewer side effects than other treatments. NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the only hospital in the Northeast to offer the new therapy.

5 Jan 2006

New treatments suggest that cancer is on the run!

People suffering from cancer will be encouraged by a cluster of recent reports on successful new treatments for several different forms of cancer.

24 Oct 2005

Treating breast cancer with "MammoSite" study

Treating breast cancer with MammoSite resulted in a low risk of complications and was generally well tolerated, according to a University of Pittsburgh School of Medicine study presented today at the 47th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

17 Oct 2005

Accelerated partial breast irradiation using balloon brachytherapy is an excellent option for women with early breast tumors

A new method of radiation -- accelerated partial breast irradiation using balloon brachytherapy -- makes it more convenient for breast cancer patients to receive radiation therapy after surgery and appears to be safe, offer good cosmetic results, and keep cancer from coming back, according to four-year results of an ongoing study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

17 Oct 2005

BSD Medical receives notice of allowance for new patent

BSD Medical today announced that the company has received "official notice of allowance" for a new patent that is expected to be issued by the U.S. Patent Office.

26 Jul 2005

Innovative new brachytherapy planning tool

The Vitesse system is being used in more than 25 hospitals worldwide to speed up planning and enable treatments to take place within a day, avoiding the need for patients to stay in a hospital overnight.

19 Jul 2005

Brachytherapy News and Research

Further Reading

Prostate brachytherapy causes fewer side effects than surgery

Seed implants critical for achieving a better prostate cancer outcome

Radiation therapy combo cures prostate cancer long-term

BlueCross BlueShield of Illinois adds coverage for MammoSite

Blue Cross Blue Shield of Illinois coverage policy for partial-breast radiation therapy to be reviewed

Variances in patterns of care for patients with prostate cancer failing primary therapy

Review identifies factors that influence patient treatment choice for localized prostate cancer

Breast radiation device associated with complications

Review identifies factors that influence patient treatment choice for localized prostate cancer

Review examines the management of radiotherapy induced rectourethal fistula

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

Sirolimus-releasing stents more effective than vascular brachytherapy for treating restenosis within a stent

Stents that release the drug paclitaxel to treat stenosis more effective than radiation therapy

Drug-eluting stents best treatment for managing coronary restenosis

New radiation therapy for prostate cancer has fewer side effects

New treatments suggest that cancer is on the run!

Treating breast cancer with "MammoSite" study

Accelerated partial breast irradiation using balloon brachytherapy is an excellent option for women with early breast tumors

BSD Medical receives notice of allowance for new patent

Innovative new brachytherapy planning tool

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News